Epidemiology, short and long-term consequences of hypoglycaemia

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 15, Issue 6, 2002, Pages 378-385

  Frier, Brian M ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cognitive function morbidity; Frequency; Hypoglycaemia; Type 1 diabetes; Type 2 diabetes

Indexed keywords

INSULIN; ISOPHANE INSULIN;

AMNESIA; BEHAVIOR DISORDER; BRAIN BLOOD FLOW; CLINICAL FEATURE; COGNITIVE DEFECT; COMA; CONVULSION; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; EVOKED RESPONSE; HUMAN; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MOOD DISORDER; MORBIDITY; MORTALITY; NEUROPHYSIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIA; INSULIN;

EID: 0036971661     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Pramming S., Thorsteinsson B., Bendtson I., Binder C.: Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet. Med. 8: 217-222, 1991.
2. Pramming S., Pederson-Bjergaard U., Heller S.R., Wallace T., Rasmussen A.K., Jorgensen H.V., Matthews D.R., Thorsteinsson B.: Severe hypoglycaemia in unselected patients with type 1 diabetes: a cross-sectional multicentre survey. Diabetologia 43 (Suppl. 1): A194 (Abstract), 2000.
3. MacLeod K.M., Hepburn D.A., Frier B.M.: Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet. Med. 10: 238-245, 1993.
4. The EuroDiab IDDM Complications Study Group: Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 37: 278-285, 1994.
5. Ter Braak E.W.M.T., Appelman A.M.M.F., van de Laak M.F., Stolk R.P., van Haeften T.W., Erkelens D.W.: Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 20: 1467-1471, 2000.
6. Diabetes Control and Complications Trial Research Group: Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 46: 271-286, 1997.
7. Reichard P., Britz A., Rosenqvist U.: Intensified conventional insulin treatment and neuropsychological impairment. Br. Med. J. 303: 1439-1442, 1991.
8. Diabetes Control and Complications Trial Resreach Group: Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am. J. Med. 90: 450-459, 1991.
9. Jorgens V., Gruber M., Bott U., Mülhauser I., Berger M.: Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia 36: 99-105, 1993.
10. Bott S., Bott U., Berger M., Mühlhauser I.: Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 40: 926-932, 1997.
11. Swift P.G.F.: Hypoglycaemia in children with diabetes. In: Frier B.M., Fisher B.M. (Eds.), Hypoglycaemia in clinical diabetes. John Wiley and Sons, Chichester, 1999, pp. 211-242.
12. Gold A.E., MacLeod K.M., Frier B.M.: Frequency of severe hypoglycemia in patients with type 1 diabetes with impaired awareness of hypoglycemia. Diabetes Care 17: 697-703, 1994.
13. Clarke W.L., Cox D.J., Gonder-Frederick L.A., Julian D., Schundt D., Polonsky W.: Reduced awareness of hypoglycemia in adults with IDDM: a prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 18: 517-522, 1995.
14. Lalli C., Ciofetta M., Del Sindaco P., Torlone E., Pampanelli S., Compagnucci P., Cartechini M.G., Bartocci P., Bolli G.B.: Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Diabetes Care 22: 468-477, 1999.
15. Bode B.W., Steed R.D., Davidson P.C.: Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 19: 324-327, 1996.
16. Boland E.A., Grey M., Oesterle A., Fredrickson L., Tamborlane W.V.: Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 22: 1779-1784, 1999.
17. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998.
18. United Kingdom Prospective Diabetes Study Group: United Kingdom Prospective Diabetes Study (UKPDS) 13: randomly allocated diet, sulphonylurea, insulin or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. Br. Med. J. 310: 83-88, 1995.
19. Henry R.R., Gumbiner B., Ditzler T., Wallace P., Lyon R., Glauber H.S.: Intensive conventional insulin therapy for type II diabetes: metabolic effects during a 6-mo outpatient trial. Diabetes Care 16: 21-31, 1993.
20. Abraira C., Colwell J.A., Nuttall F.Q., Sawin C.T., Nagel N.J., Comstock J.P., Emanuele N.V., Levin S.R., Henderson W., Lee H.S. VA CSDM Group: Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes. Results of the feasibility trial. Diabetes Care 18: 1113-1123, 1995.
21. Shorr R.I., Ray W.A., Daugherty J.R., Griffin M.R.: Incidence and risk factors for severe hypoglycemia in older persons using insulin or sulfonylureas. Arch. Intern. Med. 157: 1681-1686, 1997.
22. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., Kojima Y., Furuyoshi N., Shichiri M.: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28: 103-117, 1995.
23. Dunn F.L., Nathan D.M., Scavini M., Selam J.-L., Wingrove T.G., the Implantable Insulin Pump Trial Study Group: Long-term therapy of IDDM with an implantable insulin pump. Diabetes Care 20: 59-63, 1997.
24. Hepburn D.A., MacLeod K.M., Pell A.C.H., Scougal I.J., Frier B.M.: Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet. Med. 10: 231-237, 1993.
25. Draelos M.T., Jacobson A.M., Weinger K., Widom B., Ryan C.M., Finkelstein D.M., Simonson D.C.: Cognitive function in patients with insulin dependent diabetes melitus during hyperglycemia and hypoglycemia. Am J. Med. 98: 135-144, 1995.
26. Gold A.E., Deary I.J., MacLeod K.M., Frier B.M.: The effect of IQ level on the degree of cognitive deterioration experienced during acute hypoglycemia in normal humans. Intelligence 20: 267-290, 1995.
27. Wirsen A., Tallroth G., Lindgren M., Agardh C.-D.: Neuropsychological performance differs between type 1 diabetic and normal men during insulin-induced hypoglycaemia. Diabet. Med. 9: 156-165, 1992.
28. Gold A.E., MacLeod K.M., Deary I.J., Frier B.M.: Hypoglycemia-induced cognitive dysfunction in diabetes mellitus: effect of hypoglycemia unawareness. Physiol. Behav. 58: 501-511, 1995.
29. Blackman J.D., Towle V.L., Sturis J., Lewis G.F., Spire J.-P., Polonsky K.S.: Hypoglycemic thresholds for cognitive dysfunction in IDDM. Diabetes 41: 392-399, 1992.
30. Lindgren M., Eckert B., Stenberg G., Agardh C.-D.: Restitution of neurophysiological functions, performance and subjective symptoms after moderate insulin-induced hypoglycaemia in non-diabetic men. Diabet. Med. 13: 218-225, 1996.
31. Strachan M.W.J., Ewing F.M.E., Deary I.J., Frier B.M.: Recovery of cognitive function and mood after severe hypoglycemia in insulin-treated diabetes mellitus. Diabetes Care 23: 305-312, 2000.
32. MacLeod K.M., Hepburn D.A., Deary I.J., Goodwin G.M., Dougall N., Ebmeier K.P., Frier B.M.: Regional cerebral blood flow in IDDM patients: effects of diabetes and of recurrent severe hypoglycaemia. Diabetologia 37: 257-263, 1994.
33. Perros P., Deary I.J.: Long-term effects of hypoglycaemia on cognitive function and the brain in diabetes. In: Frier B.M., Fisher B.M. (Eds.), Hypoglycaemia in clinical diabetes, John Wiley & Sons, Chichester, 1999, pp. 187-210.
34. Ryan C.M.: Neuropsychological consequences and correlates of diabetes in childhood. In: Holmes C.S. (Ed.), Neuropsychological and behavioural aspects of diabetes. Springer, New York, 1990, pp. 58-84.
35. Northam E.A., Anderson P.J., Werther G.A., Warne G.L., Adler R.G., Andrewes D.: Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 21: 379-384, 1998.
36. Northam E.A., Anderson P.J., Werther G.A., Warne G.L., Andrewes D.: Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care 22: 1438-1444, 1999.
37. Northam E.A., Anderson P.J., Jacobs R., Hughes M., Warne G.L., Werther G.A.: Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 24: 1541-1546, 2001.
38. Deary I.J., Crawford J.R., Hepburn D.A., Langan S.J., Blackmore L.M., Frier B.M.: Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 42: 341-344, 1993.
39. Lincoln N.B., Faliero R.M., Kelly C., Kirk B.A., Jeffcoate W.J.: Effect of long-term glycemic control on cognitive function. Diabetes Care 19: 656-658, 1996.
40. Diabetes Control and Complications Trial Research Group: Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann. Intern. Med. 124: 379-388, 1996.
41. Reichard P., Pihl M.: Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes 43: 313-317, 1994.
42. Perros P., Deary I.J., Sellar R.J., Best J.J.K., Frier B.M.: Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20: 1013-1018, 1997.
43. Gold A.E., Deary I.J., Jones R.W., O'Hare J.P., Reckless J.P.D., Frier B.M.: Severe deterioration in cognitive function and personality in five patients with long-standing diabetes: a complication of diabetes or a consequence of treatment? Diabet. Med. 11: 499-505, 1994.